Table of Content

Open Access iconOpen Access

ARTICLE

Proteasome Inhibitors Diminish c-Met Expression and Induce Cell Death in Non-Small Cell Lung Cancer Cells

Yanhui Li*†, Su Dong*†, Arya Tamaskar, Heather Wang, Jing Zhao, Haichun Ma*, Yutong Zhao

* Department of Anesthesia, the First Hospital of Jilin University, Changchun, Jilin, P.R. China
† Department of Physiology and Cell Biology, Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA

Oncology Research 2020, 28(5), 497-507. https://doi.org/10.3727/096504020X15929939001042

Abstract

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and accounts for 85% of all lung carcinomas. The hepatocyte growth factor receptor (c-Met) has been considered as a potential therapeutic target for NSCLC. Proteasome inhibition induces cell apoptosis and has been used as a novel therapeutic approach for treating diseases including NSCLC; however, the effects of different proteasome inhibitors on NSCLC have not been fully investigated. The aim of this study is to determine a precise strategy for treating NSCLC by targeting c-Met using different proteasome inhibitors. Three proteasome inhibitors, bortezomib, MG132, and ONX 0914, were used in this study. Bortezomib (50 nM) significantly reduced c-Met levels and cell viability in H1299 and H441 cells, while similar effects were observed in H460 and A549 cells when a higher concentration (~100 nM) was used. Bortezomib decreased c-Met gene expression in H1299 and H441 cells, but it had no effect in A549 and H460 cells. MG-132 at a low concentration (0.5 µM) diminished c-Met levels in H441 cells, while neither a low nor a high concentration (~20 µM) altered c-Met levels in A549 and H460 cells. A higher concentration of MG-132 (5 µM) was required for decreasing c-Met levels in H1299 cells. Furthermore, MG-132 induced cell death in all four cell types. Among all the four cell lines, H441 cells expressed higher levels of c-Met and appeared to be the most susceptible to MG-132. MG-132 decreased c-Met mRNA levels in both H1299 and H441 cells. ONX 0914 reduced c-Met levels in H460, H1299, and H441 cells but not in A549 cells. c-Met levels were decreased the most in H441 cells treated with ONX 0914. ONX 0914 did not alter cell viability in H441; however, it did induce cell death among H460, A549, and H1299 cells. This study reveals that different proteasome inhibitors produce varied inhibitory effects in NSCLS cell lines.

Keywords


Cite This Article

APA Style
Li, Y., Dong, S., Tamaskar, A., Wang, H., Zhao, J. et al. (2020). Proteasome inhibitors diminish c-met expression and induce cell death in non-small cell lung cancer cells. Oncology Research, 28(5), 497-507. https://doi.org/10.3727/096504020X15929939001042
Vancouver Style
Li Y, Dong S, Tamaskar A, Wang H, Zhao J, Ma H, et al. Proteasome inhibitors diminish c-met expression and induce cell death in non-small cell lung cancer cells. Oncol Res. 2020;28(5):497-507 https://doi.org/10.3727/096504020X15929939001042
IEEE Style
Y. Li et al., "Proteasome Inhibitors Diminish c-Met Expression and Induce Cell Death in Non-Small Cell Lung Cancer Cells," Oncol. Res., vol. 28, no. 5, pp. 497-507. 2020. https://doi.org/10.3727/096504020X15929939001042



cc This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 568

    View

  • 467

    Download

  • 0

    Like

Share Link